Evaluating the safety of TKI discontinuation in adult patients with Ph+ ALL not undergoing alloSCT VJHemOnc – Video Journal of Hematology & HemOnc 1:48 1 month ago 67 Далее Скачать
The feasibility of TKI treatment discontinuation in patients with Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:33 10 months ago 86 Далее Скачать
Safety and efficacy of new TKIs in Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 41 Далее Скачать
Treatment options for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 5:23 4 years ago 599 Далее Скачать
TKI use in Ph+ and Ph-like ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:34 3 years ago 250 Далее Скачать
Recent advances in the treatment of Ph+ ALL and the important role of TKIs VJHemOnc – Video Journal of Hematology & HemOnc 2:55 2 years ago 73 Далее Скачать
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia and Treatment Options CheckRare 14:13 11 months ago 859 Далее Скачать
An update on the management of Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 years ago 263 Далее Скачать
New approaches to upfront therapy in Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:10 4 weeks ago 44 Далее Скачать
Current and emerging treatment options for Ph-like ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 215 Далее Скачать
Blinatumomab plus ponatinib for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 3:19 3 years ago 422 Далее Скачать
Optimizing treatment for Ph+ ALL: TKIs combined with chemotherapy followed by transplantation VJHemOnc – Video Journal of Hematology & HemOnc 0:58 3 months ago 75 Далее Скачать
Improving outcomes of Ph-positive ALL patients with TKIs VJHemOnc – Video Journal of Hematology & HemOnc 4:13 4 years ago 337 Далее Скачать
Final analysis of the GIMEMA LAL2116 (D-ALBA) trial: dasatinib + blinatumomab in Ph+ B-ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:59 10 months ago 98 Далее Скачать
Next generation TKIs for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:15 3 years ago 165 Далее Скачать
SWOG 1318: dasatinib plus blinatumomab in the treatment of older patients with B-ALL VJHemOnc – Video Journal of Hematology & HemOnc 3:03 10 months ago 98 Далее Скачать
The evolution of treatment of Ph+ ALL & Phase II study of blinatumomab and ponatinib in Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 9:21 2 years ago 979 Далее Скачать
The importance of understanding TKI-specific side effects to select the best option for each patient VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 129 Далее Скачать
Current strategies and future perspectives for Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:34 3 years ago 63 Далее Скачать
